| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.7B | $8.9B | $8.6B | $7.2B | $5.5B | $6.1B | $2.3B | $2.4B |
| Cost of Revenue | $7.0B | $6.9B | $6.8B | $5.9B | $4.8B | $5.7B | $7.6B | $7.0B |
| Gross Profit | $1.8B | $2.0B | $1.8B | $1.3B | $0.8B | $0.4B | $0.4B | $0.4B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.2B | $1.1B | $1.2B | $1.1B | $0.9B | $1.0B | $1.3B | $1.2B |
| Operating Income | $0.5B | $0.9B | $0.7B | $0.3B | $-0.1B | $-2.4B | $-6.3B | $0.2B |
| Net Income | $0.1B | $0.6B | $1.0B | $0.2B | $-0.3B | $-2.5B | $-0.4B | $0.0B |
| EPS (Basic) | $0.39 | $1.62 | $2.53 | $0.40 | $-0.65 | $-6.62 | $-1.01 | $0.03 |
| EPS (Diluted) | $0.39 | $1.60 | $2.50 | $0.39 | $-0.65 | $-6.62 | $-1.01 | $0.03 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.3B | $11.4B | $11.3B | $10.1B | $9.6B | $9.9B | $13.1B | $19.8B |
| Current Assets | $5.8B | $5.8B | $5.8B | $5.5B | $4.9B | $5.2B | $6.1B | $7.3B |
| Cash & Equivalents | $1.6B | $1.2B | $0.8B | $1.1B | $1.6B | $1.7B | $1.2B | $1.4B |
| Total Liabilities | $5.0B | $4.9B | $5.1B | $5.0B | $4.5B | $4.7B | $5.3B | $5.9B |
| Current Liabilities | $2.4B | $2.3B | $2.4B | $2.4B | $1.9B | $1.9B | $2.2B | $2.3B |
| Stockholders' Equity | $6.3B | $6.4B | $6.2B | $5.1B | $5.0B | $5.2B | $7.8B | $13.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.3B | $1.3B | $0.1B | $-0.2B | $0.3B | $0.9B | $0.7B | $0.5B |
| Investing Cash Flow | $-0.4B | $-0.5B | $-0.3B | $-0.2B | $-0.2B | $-0.1B | $-0.3B | $-0.5B |
| Capital Expenditures | $0.4B | $0.4B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| Financing Cash Flow | $-0.6B | $-0.4B | $-0.1B | $-0.1B | $-0.2B | $-0.3B | $-0.6B | $-0.0B |